Press Release

May 16, 2022

Albert Labs Granted Health Canada Licence

Albert Labs, today announced that it has received conditional approval for the listing of its…

Albert Labs

Love0

Press Release

May 12, 2022

Albert Labs’ Pre-Clinical Analytical and Toxicological Research Supports Company’s Forthcoming Studies

Albert Labs, today announced that it has received conditional approval for the listing of its…

Albert Labs

Love0

Press Release

April 26, 2022

Albert Labs Announces the Addition of Two Renowned Scientific Advisors to its Scientific Advisory Board (SAB)

Albert Labs, today announced that it has received conditional approval for the listing of its…

Albert Labs

Love0

Press Release

March 30, 2022

Albert Labs Files US Provisional Patent Application and Proves Out Consistent and Rapidly Scalable Production of Psilocybe and Other Mycelia

Albert Labs, today announced that it has received conditional approval for the listing of its…

Albert Labs

Love0

Press Release

March 10, 2022

Albert Labs (CSE:ABRT) Closes $4.7m Private Placement; Begins Trading on the Canadian Securities Exchange

Albert Labs, today announced that it has received conditional approval for the listing of its…

Albert Labs

Love0

Press Release

January 4, 2022

Press Release: MHRA Guidance on the use of Real-World Data in Clinical Studies for Regulatory Decision-Making Supports Albert Labs’ Licensing Pathway

Albert Labs, today announced that it has received conditional approval for the listing of its…

Albert Labs

Love0

Press Release

November 29, 2021

Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing

Albert Labs, today announced that it has received conditional approval for the listing of its…

Albert Labs

Love0

Press Release

June 24, 2021

Albert Labs announces distinguished clinical and scientific advisory boards

Albert Labs Scientific and Clinical Advisory Boards will support the company’s efforts to develop its…

Albert Labs

Love0

Press Release

June 3, 2021

MEC Announces Submission Of Listing Statement To The CSE In Coordination with Albert Labs RTO

Albert Labs going public soon. JUNE 03 , 2021 - VANCOUVER, BRITISH COLUMBIA, ME Resource Corp…

Albert Labs

Love0

Press Release

May 25, 2021

Adding To Their Expert Team, Albert Labs Announces The Formation And Chairs Of Its Two Advisory Boards.

Professor Jo Neill and Parminder Singh bring psychopharmacology and IP protection & licensing expertise to…

Albert Labs

Love0

Press Release

Albert Labs Granted Health Canada Licence

Albert Labs’ Pre-Clinical Analytical and Toxicological Research Supports Company’s Forthcoming Studies

Albert Labs Announces the Addition of Two Renowned Scientific Advisors to its Scientific Advisory Board (SAB)

Albert Labs Files US Provisional Patent Application and Proves Out Consistent and Rapidly Scalable Production of Psilocybe and Other Mycelia

Albert Labs (CSE:ABRT) Closes $4.7m Private Placement; Begins Trading on the Canadian Securities Exchange

Press Release: MHRA Guidance on the use of Real-World Data in Clinical Studies for Regulatory Decision-Making Supports Albert Labs’ Licensing Pathway

Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing

Albert Labs announces distinguished clinical and scientific advisory boards

MEC Announces Submission Of Listing Statement To The CSE In Coordination with Albert Labs RTO

Adding To Their Expert Team, Albert Labs Announces The Formation And Chairs Of Its Two Advisory Boards.

Innovative mental health medicines for patients with unmet needs.

Navigate

About

Team

News

Contact

Connect

info@albertlabs.com

Get in touch

About Salient